Nutritional intervention in berardinelli syndrome or generalized congenital lipoatrophy: case report
Abstract
Introduction and Objectives: Generalized Congenital Lipoatrophy is a rare, autosomal recessive, low prevalence genetic disorder whose diagnosis accompanies several metabolic and systemic alterations, most notably diabetes mellitus, systemic arterial hypertension, hepatic steatosis, dyslipidemia and renal failure. The main objective is to report how the Nutritional Interference in Generalized Congenital Lipoatrophy improves the health status of patients. Materials and Methods: This is an exploratory case study with a qualitative approach, carried out in the city of Juazeiro do Norte-CE. From the reading and interpretation of the medical record, information and menu application were obtained to improve biochemical rates. Discussion: Within the many metabolic changes installed, characteristics of the syndrome, dietary intervention is a form of treatment. Together with the practice of physical activity and medications, they improved the quality of life and, consequently, the life expectancy of the patients. The achievement of nutritional goals in treatment is variable and depends on adherence to diet. Dietary guidelines recommend: restriction of total energy intake, saturated fat and simple carbohydrates, giving preference to the consumption of complex carbohydrates, soluble fibers, medium chain triglycerides and unsaturated fatty acids and drug therapy. Results and Conclusion: Regarding the literature on the most adequate diet therapy in Generalized Congenital Lipodystrophy, the relevance of the topic is still relevant, since the use of adequate diet therapy improves the patient's metabolic status, improving the biochemical rates and the expectation of life of the carriers.
References
-Barra, C.B.; Savoldelli, S.V.; Manna, T.D.; Kim, C.A.; Magre, J.; Porta, G.; Setian, N.; Damiani, D. Síndrome de Berardinelli-Seip: descrição genética e metabólica de cinco pacientes. Arq Bras Endocrinol Metab. Vol. 55. Num. 1. 2011. p. 54-59.
-Brown, R.J.; Araujo-Vilar, D.; Cheung, Pik.; Dunger D.; Garg, A.; Jack, M.; Mungai, L.; Oral, E.A.; Patni, N.; Rother, K.I.; von Schnurbein, J.; Sorkina, E.; Stanley, T.; Vigouroux, C.; Wabitsch, M.; Williams, R.; Yorifuji, T.; The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Vol. 101. Num. 12. 2016. p. 4500-4511.
-Damasceno, É.B.; Figueiredo, J.G.; França, J.M.B.; Veras, J.C.D.; Borges, R.E. A.; Melo, L.P. Experiência de pessoas que vivem com a Síndrome de Berardinelli-Seip no Nordeste brasileiro. Faculdade de Ciências da Saúde do Trairí. UFRN. Santa Cruz-RN. Brasil. Ciência & Saúde Coletiva. Vol. 23. Num. 2. 2018. p. 389-398.
-Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification. 2003.
-Diretrizes, Sociedade Brasileira de Diabetes. Princípios para orientação nutricional no diabetes mellitus. São Paulo-SP. 2014-2015.
-Fiorenza, C.G.; Chou, S.H.; Mantzoros, C.S. Lipodystrophy: Pathophysiology and Advances in Treatment. Nat Rev Endocrinol. Vol. 7. Num. 3. 2011. p. 137-150.
-Lima, J.G.; Nobrega, L.H.C.; Lima, N.N.; Santos, M.G.N.; Baracho, M.F.P.; Jeronimo,S.M.B. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetology & Metabolic Syndrome. Vol. 8. Num. 23. 2016.
-Patni, N.; Garg, A. Congenital generalized lipodystrophies-new insights into metabolic dysfunction. Nat. Rev. Endocrinol. Vol. 11. Num. 9. 2015. p. 522-534.
-Ponte, C.M.M. neuropatia autonômica cardiovascular precoce em pacientes com Lipodistrofia Generalizada Congênita. Tese de Doutorado. Fortaleza. Universidade Federal do Ceará. 2016.
-Sociedade Brasileira de Cardiologia. Arquivos Brasileiros de Cardiologia. Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose-2017. Vol. 109. Num. 2. 2017.
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with work simultaneously licensed under the Creative Commons Attribution License BY-NC which allows the sharing of the work with acknowledgment of the authorship of the work and initial publication in this journal.
- Authors are authorized to enter into additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this can bring about productive change as well as increase impact and impact. citation of published work (See The Effect of Free Access).